The increased expression of PICOT protein in a variety of cancers, including Hodgkin’s lymphoma11 and breast7, colon12, and lung carcinoma12, encouraged us to test whether the negative correlation between PICOT and CCND2 expression, which was observed in Jurkat T cells, also exists in human cancers. Here, GLRX3 is linked to cancer.